CALX Form 144: planned sales of 395,000 and 25,000 shares on NYSE

CALX filed a Form 144 notice for proposed sales of common stock, listing 395,000 shares (via J.P.

Rhea-AI Filing Summary

CALX filed a Form 144 notice for proposed sales of common stock, listing 395,000 shares (via J.P. Morgan Securities) and 25,000 shares (via Wells Fargo Clearing Services). The filing shows aggregate market values of $25,280,000 and $1,639,367, respectively, with an approximate sale date of 11/04/2025 on the NYSE.

The notice also lists how the seller acquired the shares over time, including purchases on 12/21/1999 (102,704 shares), 06/23/2000 (75,476), 02/23/2001 (13,658), 06/12/2002 (203,162), and a stock option exercise on 01/30/2023 (25,000). Shares outstanding were 66,276,473; this is a baseline figure, not the amount being sold.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does CALX’s Form 144 disclose?

A proposed sale of common stock, including 395,000 shares via J.P. Morgan Securities and 25,000 shares via Wells Fargo Clearing Services, to be sold on the NYSE.

How many CALX shares are proposed for sale and through which brokers?

395,000 shares via J.P. Morgan Securities and 25,000 shares via Wells Fargo Clearing Services.

What is the aggregate market value of the proposed CALX sales?

J.P. Morgan tranche: $25,280,000; Wells Fargo tranche: $1,639,367.

When are the CALX sales planned to occur?

The approximate date of sale is 11/04/2025.

On which exchange are the CALX shares to be sold?

The filing lists the NYSE.

How many CALX shares are outstanding?

Shares outstanding were 66,276,473.

How were the CALX shares acquired by the seller?

Purchases from the issuer on 12/21/1999 (102,704), 06/23/2000 (75,476), 02/23/2001 (13,658), 06/12/2002 (203,162), and a 01/30/2023 stock option exercise (25,000).

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 11/04/2025 - 06:32 PM EST Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001483757
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	CALIX, INC
SEC File Number	001-34674
Address of Issuer	3155 Olsen Drive Suite 450 San Jose CALIFORNIA 95117
Phone	408-514-3000
Name of Person for Whose Account the Securities are To Be Sold	Carl Russo
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer
Relationship to Issuer	Director
Relationship to Issuer	10% Stockholder

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	J.P. Morgan Securities LLC 270 Park Ave - Floor 10 New York NY 10017	395000	25280000	66276473	11/04/2025	NYSE
Common	Wells Fargo Clearing Services One North Jefferson Avenue St. Louis MO 63103	25000	1639367	66276473	11/04/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	12/21/1999	Purchase	Issuer			102704	12/21/1999	n/a
Common	06/23/2000	Purchase	Issuer			75476	06/23/2000	n/a
Common	02/23/2001	Purchase	Issuer			13658	02/23/2001	n/a
Common	06/12/2002	Purchase	Issuer			203162	06/12/2002	n/a
Common	01/30/2023	Stock Option Exercise	Issuer			25000	01/30/2023	n/a

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks	The 420,000 shares are being sold by the Crescentico Trust, and Carl Russo is a Trustee of the Trust. He is also a Director Officer and a ten percent shareholder of Calix Inc. The proposed sale of up to 25,000 of these shares through Wells Fargo Clearing Services are being made pursuant to a Sales Plan adopted on April 25, 2025
Date of Notice	11/04/2025
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	04/25/2025
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ J.P. Morgan Securities LLC as agent and attorney-in-fact for Carl Russo
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)